App-Quantinova.ai

SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE ANKYLOSING SPONDYLITIS: 2-YEAR RESULTS FROM A PHASE 3 TRIAL WITH SUBCUTANEOUS LOADING AND MAINTENANCE DOSING (MEASURE 2)

H. Marzo-Ortega - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

secukinumab

PENTRAXIN 3 AS BIOMARKER IN ASSESSMENT OF DISEASE ACTIVITY IN TAKAYASU ARTERITIS

P.K. Devarasetti - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Takayasu arteritis

N/A

Oxidated Lipids in Early Atherosclerosis in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus

N.A. Bashlakova - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

ILS-969

Fatty Liver Index Predicts Glucose Metabolism Disturbance in Inflammatory Arthritis Patients

C. Tripolino - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Inflammatory Arthritis

N/A

Comparative Efficacy of Methotrexate and Colchicine in CPPD and Chronic Arthritis Patients

S. Vladimirov - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Methotrexate

Tildrakizumab Treatment Improved Measures of Psoriatic Arthritis in Adults with Chronic Plaque Psoriasis

R.G. Langley - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Psoriatic arthritis

Tildrakizumab

Pentraxin 3 as Biomarker in Assessment of Disease Activity in Takayasu Arteritis

P.K. Devarasetti - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Takayasu arteritis

N/A

The Predictive Role of High Sensitive C-Reactive Protein and High Density Lipoprotein in Development of Rotator Cuff Tear in Patients with Hand Osteoarthritis

H.-O. Kim - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Osteoarthritis 2

N/A

Correlation Analysis of Serum Cystatin C and Lipids Levels in Patients with Systemic Lupus Erythematosus

Z. Ye - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

of IL-1 Gene Cluster Polymorphism and Its Relationship with Clinical Findings in Patients with Gout

E. Calvo Aranda - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Coronary Artery Disease

Angiotensin II

Factors Associated with Preclinical Atherosclerotic Changes in Carotid Artery in Men with Gout

H. Tag - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Coronary Artery Disease

N/A

Periodontal Disease in Spondyloarthritis Subtypes. Is There A Difference?

J.C. Rueda - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Periodontal disease

N/A

Does The Cytokine Pattern, Including The IL23 - IL17 Immune Axis, Change in Pregnant Women with Psoriatic Arthritis?

A. Pluma Sanjurjo - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

Interleukin

Increased Insulin Resistance and Impaired Beta-Cell Function in Patients with Rheumatoid Arthritis: Could Inflammation Fully Explain These Metabolic Disturbances?

G.G. Ristic - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

Liver Fat Indices Relate with Inflammatory Profile in Inflammatory Arthritis Patients

C. Bruno - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Inflammatory Arthritis

N/A

Determinants Of Tissue Iron Loading In Transfused and Non-Transfused ?-Thalassemia and Sickle Cell Disease Patients Biomarkers Of Iron Regulation and Inflammation

Patrick B Walter - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Sickle cell anemia

N/A

Microparticles As Biomarkers Of Osteonecrosis Of The Hip In Sickle Cell Disease

Anne M Marsh - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Acute chest syndrome

N/A

Activated Factor VIIAntithrombin Complex Plasma Concentration Is An Independent Predictor Of Total and Cardiovascular Mortality In Patients With Coronary Artery Disease and Its Prognostic Significance Is Improved By Using Factor VII Genotype-Specific Threshold Levels

Nicola Martinelli - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

N/A

KINERET (ANAKINRA) CONTROLS DISEASE SYMPTOMS IN PATIENTS WITH SEVERE CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS): UP TO 5-YEAR FOLLOW-UP DATA

H. Olivecrona - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Inflammatory Arthritis

Anakinra

AN ASSESSMENT OF CHRONIC SYNOVIAL-BASED INFLAMMATION AND ITS ROLE WITH SERUM URATE LEVELS

J. Carter - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Inflammatory Arthritis

Colchicine

Filters

1408 Abstracts